Spyre Therapeutics (SYRE) Tax Rate (2021 - 2025)

Spyre Therapeutics (SYRE) has 5 years of Tax Rate data on file, last reported at 0.03% in Q1 2025.

• For the quarter ending Q1 2025, Tax Rate rose 11.0% year-over-year to 0.03%; the trailing twelve-month figure through Dec 2025 stood at 0.01% (up 3.0% YoY), and the FY2025 full-year result was 0.01%, up 3.0% from the prior year.
• Tax Rate for Q1 2025 stood at 0.03%, up from 0.0% in the prior quarter.
• Across five years, Tax Rate topped out at 1.13% in Q3 2022 and bottomed at 1.37% in Q2 2021.
• The 5-year median for Tax Rate is 0.03% (2024), against an average of 0.05%.
• The widest annual swing landed in 2022, when Tax Rate soared 133 bps; it then tumbled 114 bps in 2023.
• A 5-year view of Tax Rate shows it stood at 0.11% in 2021, then plunged by 80 bps to 0.2% in 2022, then soared by 96 bps to 0.01% in 2023, then surged by 76 bps to 0.0% in 2024, then soared by 1985 bps to 0.03% in 2025.
• The last three Tax Rate figures came in at 0.03% (Q1 2025), 0.0% (Q4 2024), and 0.03% (Q3 2024), per Business Quant data.

Peer Comparison